1
|
Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata. Animals (Basel) 2023; 13:ani13050870. [PMID: 36899726 PMCID: PMC10000124 DOI: 10.3390/ani13050870] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 02/17/2023] [Accepted: 02/19/2023] [Indexed: 03/06/2023] Open
Abstract
In the multimodal management of osteoarthritis (OA) in recent decades, the use of feed supplements to maintain joint cartilage has been advocated. The aim of this scoping review is to present the results found in the veterinary literature on the use of undenatured type II collagen and Boswellia serrata in dogs, specifically its use in dogs with clinical signs of OA, healthy dogs after intense exercise or dogs with diseases that predispose the individual to OA. For this purpose, a literature review was carried out using the electronic databases PubMed, Web of Science and Google Scholar, from which a total of 26 records were included in this review: fourteen evaluating undenatured type II collagen, ten evaluating Boswellia serrata and two evaluating the combination of undenatured type II collagen and Boswellia serrata. The review of the records showed that undenatured type II collagen decreases the clinical signs associated with OA, improving the general clinical state with a reduction in the degree of lameness and increase in physical activity or mobility. Evaluating the response to supplementation with Boswellia serrata alone is complicated due to the limited publication of studies and variations in the purity and compositions of the products used, but in general terms, its combination with other feed supplements produces benefits by relieving pain and reducing the clinical signs of OA in dogs. The combination of both in the same product provides results similar to those obtained in undenatured type II collagen studies. In conclusion, undenatured type II collagen and Boswellia serrata are considered a valid option for the multimodal approach to the management of OA and for improving activity during intense exercise, but more studies are needed to conclude whether or not it prevents OA in dogs.
Collapse
|
2
|
della Rocca G, Schievano C, Di Salvo A, Conti MB, della Valle MF. Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain. BMC Vet Res 2023; 19:37. [PMID: 36747264 PMCID: PMC9903516 DOI: 10.1186/s12917-023-03594-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Accepted: 01/27/2023] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND Osteoarthritis (OA) pain is the number one cause of chronic pain in dogs. Multimodal treatment, including combining safe and effective nutritional interventions with non-steroidal anti-inflammatory drugs (NSAIDs), is currently considered one of the most appropriate choices for managing OA pain. Palmitoyl-glucosamine is a feed material belonging to the ALIAmide family, whose parent molecule is the prohomeostatic lipid amide N-palmitoyl-ethanolamine. Curcumin is a promising plant antioxidant. The present study aimed at investigating whether 18-week dietary integration with palmitoyl-glucosamine co-micronized with curcumin was able to maintain pain relief in dogs with OA-associated chronic pain receiving meloxicam (1.5 mg/ml oral suspension) on a tapering regimen (progressive 25% decrease of the original 0.1 mg/kg/day dose, on a biweekly basis) during the first 8 weeks of treatment. Pain was assessed both by the owners and veterinary surgeons, with the first using both subjective evaluation and validated metrology instruments-i.e., Helsinki Chronic Pain Index (HCPI) and Canine Brief Pain Inventory (CBPI)-while the second rating the severity of lameness and pain on palpation on two previously used 5-point scales. RESULTS A total of fifty-eight dogs with OA chronic pain entered the uncontrolled study. Pain on HCPI was considered severe at baseline (range 18-39). Based on owner's assessment, 90% of dogs who responded to meloxicam at the full-dose regimen could reduce meloxicam up to 25% of the original dose without experiencing pain worsening. Moreover, 75% of dogs was assessed as having no pain increase ten weeks after meloxicam withdrawal. A statistically significant decrease of pain severity as scored by HCPI (P < 0.0001) was observed two and ten weeks after meloxicam withdrawal compared to study entry (17.0 ± 1.05 and 15.1 ± 1.02, respectively, vs 29.0 ± 0.74; mean ± SEM). After meloxicam withdrawal, no statistically significant change in the CBPI scores was recorded. Pain on palpation and lameness significantly changed to less severe distributions along the study period (P < 0.0001). CONCLUSION The findings appear to suggest that dietary integration with palmitoyl-glucosamine co-micronized with curcumin was able to maintain meloxicam-induced pain relief in dogs with severe OA chronic pain.
Collapse
Affiliation(s)
- Giorgia della Rocca
- grid.9027.c0000 0004 1757 3630Department of Veterinary Medicine, Centro Di Ricerca Sul Dolore Animale (CeRiDA), Università Degli Studi Di Perugia, 06123 Perugia, Italy
| | - Carlo Schievano
- Innovative Statistical Research SRL, Prato Della Valle 24, 35123 Padua, Italy
| | - Alessandra Di Salvo
- grid.9027.c0000 0004 1757 3630Department of Veterinary Medicine, Centro Di Ricerca Sul Dolore Animale (CeRiDA), Università Degli Studi Di Perugia, 06123 Perugia, Italy
| | - Maria Beatrice Conti
- grid.9027.c0000 0004 1757 3630Department of Veterinary Medicine, Centro Di Ricerca Sul Dolore Animale (CeRiDA), Università Degli Studi Di Perugia, 06123 Perugia, Italy
| | - Maria Federica della Valle
- CeDIS (Centro di Documentazione e Informazione Scientifica), Innovet Italia SRL, Via Leonardo da Vinci 3, 35030 Saccolongo, Italy
| |
Collapse
|
3
|
Abou Zaid ES, Mansour SZ, El-Sonbaty SM, Moawed FSM, Kandil EI, Haroun RAH. Boswellic acid coated zinc nanoparticles attenuate NF-κB-mediated inflammation in DSS-induced ulcerative colitis in rats. Int J Immunopathol Pharmacol 2023; 37:3946320221150720. [PMID: 36600460 PMCID: PMC9830081 DOI: 10.1177/03946320221150720] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
INTRODUCTION Ulcerative colitis (UC) is a chronic non-specific inflammatory bowel disease, and until now therapeutic agents for UC still cannot exert satisfied effects. Therefore, this study aimed to investigate the ameliorative effect of boswellic acid coated zinc nanoparticles (BAs-ZnNPs) on dextran sodium sulphate (DSS) induced-UC in rats. METHODS Rats were divided into five groups; control, BAs-ZnNPs, DSS, DSS+BAs, and DSS + BAs-ZnNPs. The activity of alkaline phosphatase (ALP) was determined colorimetrically, while the concentration of IgM, IgG, TNF-α, IL-1β, and IL-8 were measured by ELISA. Levels of gene expression of NF-κB and COX-2 genes were evaluated by RT-qPCR, while the expression of protein levels of PI3K and STAT-3 were done by western blotting. Finally, histopathological examination of colon tissues of different groups of rats was done. RESULTS The depicted ball-like structure of the BAs-ZnNPs in the TEM images ranging in size from 50 to 100 nm in diameter while their formation was confirmed by UV-visible spectroscopy with a sharp peak of maximum absorbance at 266 nm. Our results revealed that BAs-ZnNPs exerted an anti-inflammatory effect in the experimental model of colitis, demonstrated histologically and biochemically as shown by the improvement of ALP, IgM, IgG, and the gene expression levels of NF-κB and COX-2. Also, this beneficial effect was associated with the reduction in the expression of TNF-α, IL-1β, IL-8, PI3K, and STAT-3. Thus, this effect improves the altered immune response associated with the colonic inflammation. CONCLUSION BAs-ZnNPs can be proposed as a therapeutic candidate to attenuate UC. The potential underlying mechanism includes suppression of ALP, IgM, IgG, IL-1β, and IL-8 levels via regulation of NF-κB and COX-2 gene expression and STAT-3 and PI3K protein expression in a UC rat model.
Collapse
Affiliation(s)
- Eman S Abou Zaid
- Biochemistry Department, Faculty of
Science, Ain Shams
University, Cairo, Egypt
| | - Somya Z Mansour
- Radiation Biology Department,
National
Centre for Radiation Research and Technology, Atomic Energy
Authority, Cairo, Egypt
| | - Sawsan M El-Sonbaty
- Radiation Microbiology Department,
National
Centre for Radiation Research and Technology, Atomic Energy
Authority, Cairo, Egypt
| | - Fatma SM Moawed
- Health Radiation Research
Department, National
Centre for Radiation Research and Technology, Atomic Energy
Authority, Cairo, Egypt
| | - Eman I Kandil
- Biochemistry Department, Faculty of
Science, Ain Shams
University, Cairo, Egypt
| | - Riham Abdel-Hamid Haroun
- Biochemistry Department, Faculty of
Science, Ain Shams
University, Cairo, Egypt,Riham Abdel-Hamid Haroun, Faculty of
Science, Ain Shams University, El-Khalyfa El-Mamoun Street Abbasya, Cairo 11566,
Egypt.
| |
Collapse
|
4
|
Liao Y, Guo C, Wen A, Bai M, Ran Z, Hu J, Wang J, Yang J, Ding Y. Frankincense-Myrrh treatment alleviates neuropathic pain via the inhibition of neuroglia activation mediated by the TLR4/MyD88 pathway and TRPV1 signaling. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2023; 108:154540. [PMID: 36379093 DOI: 10.1016/j.phymed.2022.154540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 10/26/2022] [Accepted: 11/04/2022] [Indexed: 06/16/2023]
Abstract
BACKGROUND Neuroglia are important modulators of neuronal functionality, and thus play an integral role in the pathogenesis and treatment of neuropathic pain (NP). According to traditional Chinese medicine, Frankincense-Myrrh is capable of "activating blood and dissipating blood stasis", and as such these two biological compounds are commonly used to treat NP, however, the mechanisms underlying the efficacy of such treatment are unclear. PURPOSE This study aimed to further elucidate the protective effects associated with the Frankincense-Myrrh treatment of NP. METHODS A chronic sciatic nerve compression injury (CCI) model of NP was established, after which animals were gavaged with Frankincense, Myrrh, Frankincense-Myrrh, or the positive control drug pregabalin for 14 days. Network pharmacology approaches were used to identify putative pathways and targets associated with the Frankincense-Myrrh-mediated treatment of NP, after which these targets were subjected to in-depth analyses. The impact of TLR4 blockade on NP pathogenesis was assessed by intrathecally administering a TLR4 antagonist (LRU) or the MyD88 homodimerization inhibitory peptide (MIP). RESULTS Significant alleviation of thermal and mechanical hypersensitivity in response to Frankincense and Myrrh treatment was observed in NP model mice, while network pharmacology analyses suggested that the pathogenesis of NP may be related to TLR4/MyD88-mediated neuroinflammation. Consistently, Frankincense-Myrrh treatment was found to reduce TLR4, MyD88, and p-p65 expression in spinal dorsal horn neuroglia from treated animals, in addition to inhibiting neuronal TRPV1 and inflammatory factor expression. Intrathecal LRU and MIP delivery were sufficient to alleviate thermal and mechanical hyperalgesia in these CCI model mice, with concomitant reductions in neuronal TRPV1 expression and neuroglial activation in the spinal dorsal horn. CONCLUSION These data suggest that Frankincense-Myrrh treatment was sufficient to alleviate NP in part via inhibiting TLR4/MyD88 pathway and TRPV1 signaling activity. Blocking TLR4 and MyD88 activation may thus hold value as a means of treating NP.
Collapse
Affiliation(s)
- Yucheng Liao
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China; School of Pharmacy, Xinjiang Medical University, Urumqi, China
| | - Chao Guo
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Aidong Wen
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Min Bai
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Zheng Ran
- School of Pharmacy, Xinjiang Medical University, Urumqi, China
| | - Junping Hu
- School of Pharmacy, Xinjiang Medical University, Urumqi, China
| | - Jingwen Wang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
| | - Jianhua Yang
- School of Pharmacy, Xinjiang Medical University, Urumqi, China; Department of Pharmacy, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, China.
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
| |
Collapse
|
5
|
Virag Y, Gumpenberger M, Tichy A, Lutonsky C, Peham C, Bockstahler B. Center of pressure and ground reaction forces in Labrador and Golden Retrievers with and without hip dysplasia at 4, 8, and 12 months of age. Front Vet Sci 2022; 9:1087693. [PMID: 36619950 PMCID: PMC9814507 DOI: 10.3389/fvets.2022.1087693] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 12/06/2022] [Indexed: 12/24/2022] Open
Abstract
Canine hip dysplasia (CHD) is a common orthopedic disease. Owing to the importance of CHD in affected dogs, both clinically and for their use in breeding or work, increasing attention is being given to early diagnosis. Therefore, early clinical and radiological examination of young animals is increasingly in demand, whereas common CHD screening according to the Fédération Cynologique Internationale (FCI) is usually performed at the age of 12 months or even older in Europe. One way to objectively evaluate gait pattern is to measure the ground reaction forces (GRFs) and center of pressure (COP). In this study, we used a pressure plate to evaluate the GRF and COP parameters for 32 Labrador Retrievers and 17 Golden Retrievers at 4, 8, and 12 months of age. The dogs also underwent radiological examination of the hip joints following the FCI rules at the age of at least 12 months, which were grouped as sound (FCI grade A or B) and diseased (FCI grade C or worse). The results revealed significantly higher COP values in both breeds in the diseased limb groups at any measurement point during walking, with the most pronounced results obtained at 8 months of age. Furthermore, COP values during walking were significantly higher at 4 months than at 8 and 12 months in both the sound and diseased limb groups, indicating an increased stability of the gait pattern. Except for COP-Speed, the values of all COP parameters were higher during walking than during trotting at 4 months of age (i.e., COP-Speed was higher when trotting), indicating that the 4-beat gait in walk is more difficult to control for puppies than the 2-beat gait in trot. Overall, our results support the early evaluation of CHD in growing animals using non-invasive methods.
Collapse
Affiliation(s)
- Yvonne Virag
- Section of Physical Therapy, Small Animal Surgery, Department of Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria
| | - Michaela Gumpenberger
- Diagnostic Imaging, Department of Companion Animals and Horses, University of Veterinary Medicine, Vienna, Austria
| | - Alexander Tichy
- Department of Biomedical Sciences, Bioinformatics and Biostatistics Platform, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Christiane Lutonsky
- Section of Physical Therapy, Small Animal Surgery, Department of Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria
| | - Christian Peham
- Department of Companion Animals and Horses, Movement Science Group, University Clinic for Horses, University of Veterinary Medicine, Vienna, Austria
| | - Barbara Bockstahler
- Section of Physical Therapy, Small Animal Surgery, Department of Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria,*Correspondence: Barbara Bockstahler
| |
Collapse
|
6
|
A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Int J Mol Sci 2022; 23:ijms231810384. [PMID: 36142319 PMCID: PMC9499673 DOI: 10.3390/ijms231810384] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Revised: 09/04/2022] [Accepted: 09/04/2022] [Indexed: 11/17/2022] Open
Abstract
With osteoarthritis being the most common degenerative disease in pet animals, a very broad panel of natural health products is available on the market for its management. The aim of this systematic review and meta-analysis, registered on PROSPERO (CRD42021279368), was to test for the evidence of clinical analgesia efficacy of fortified foods and nutraceuticals administered in dogs and cats affected by osteoarthritis. In four electronic bibliographic databases, 1578 publications were retrieved plus 20 additional publications from internal sources. Fifty-seven articles were included, comprising 72 trials divided into nine different categories of natural health compound. The efficacy assessment, associated to the level of quality of each trial, presented an evident clinical analgesic efficacy for omega-3-enriched diets, omega-3 supplements and cannabidiol (to a lesser degree). Our analyses showed a weak efficacy of collagen and a very marked non-effect of chondroitin-glucosamine nutraceuticals, which leads us to recommend that the latter products should no longer be recommended for pain management in canine and feline osteoarthritis.
Collapse
|
7
|
Gabriele V, Bisanzio D, Riva A, Meineri G, Adami R, Martello E. Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments: a randomised, placebo-controlled and double-blind clinical trial. Nat Prod Res 2022; 37:1782-1786. [PMID: 36067506 DOI: 10.1080/14786419.2022.2119967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
Abstract
Dogs are commonly affected by Osteoarthritis (OA). Different approaches can be used to alleviate animals' symptoms. In this randomised, placebo-controlled and double-blind clinical trial, we performed a three months follow-up study assessing the efficacy of a food supplement containing natural ingredients (Cannabis sativa oil, Boswellia serrata Roxb. Phytosome® and Zingiber officinale extract) in dogs with OA after the interruption of physiotherapy that was performed during the previous three months. Inflammation and oxidative stress were reduced in the treated group (higher glutathione (GSH) and lower C-reactive protein [CRP] levels in blood) as well as chronic pain.
Collapse
Affiliation(s)
| | | | | | - Giorgia Meineri
- Department of Veterinary Sciences, University of Turin, Grugliasco, Italy
| | | | - Elisa Martello
- Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK
| |
Collapse
|
8
|
Della Valle G, Caterino C, Aragosa F, Balestriere C, Piscitelli A, Di Palma C, Pasolini MP, Fatone G. Relationship between Ground Reaction Forces and Morpho- Metric Measures in Two Different Canine Phenotypes Using Regression Analysis. Vet Sci 2022; 9:vetsci9070325. [PMID: 35878342 PMCID: PMC9319289 DOI: 10.3390/vetsci9070325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 06/23/2022] [Accepted: 06/24/2022] [Indexed: 11/21/2022] Open
Abstract
Simple summary The force plate gait analysis is considered the gold standard for the objective assessment of limb function in dogs. Force plate analysis has been employed in several studies using a cohort of healthy dogs as a control group. However, these studies do not consider the subject variability within the same breed. Moreover, the lack of a rigorous analysis of morphometric variabilities in the same breed makes these evaluations poorly reliable. This prospective study aims to investigate the relationship between the ground reaction forces obtained by the force plate gait analysis and the morphometric measures in two different domestic dogs’ morphotypes. Our results highlighted how the ground reaction forces are influenced by morphometric measures not so much as a single contribution, but through the interaction between them. Indeed, the interaction between body weight, withers height, and velocity significantly influenced ground reaction forces with a greater unit increase for mesomorphs. Statistical models used in the available literature only partially explain the influence of morphometric measures on ground reaction forces, and the comparison between dogs should be made not referring to the breeds but the canine morphotype. Abstract Force plate analysis assesses gait symmetry and limb loading. However, as previously described, individual and breed variability (body size and conformation) is related to breeding, body conformation, and size. This prospective study aimed to evaluate the influence of morphometric measures on the speed (V), peak of vertical force (PVF), vertical impulse (VI), and stance time (ST) in healthy dolichomorph and mesomorph dogs and their combined effect on and interactions with V, PVF, VI, and ST in the same morphological types. Fifty dogs were enrolled in the current study, and specific morphometric measurements were recorded for each dog. A force platform was used to record the ground reaction forces (GFRs), including PVF and VI. Multiple linear regression models were used for the study purposes. According to our results, GFRs are influenced by morphometric measures (body weight, withers height, and speed) not so much as a single contribution, but by the interaction between them. It is not possible to compare GFRs in dogs that do not belong to the same breed. However, the subjective variabilities make this comparison difficult and poorly reliable. According to the author, the comparison should be made between canine morphological types rather than breeds.
Collapse
Affiliation(s)
- Giovanni Della Valle
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
| | - Chiara Caterino
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
| | - Federica Aragosa
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
- Correspondence: ; Tel.: +39-0812536025; Fax: +39-0812536020
| | | | - Alfonso Piscitelli
- Department of Agricultural Sciences, University of Naples “Federico II”, 80056 Portici, Italy;
| | - Cristina Di Palma
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
| | - Maria Pia Pasolini
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
| | - Gerardo Fatone
- Department of Veterinary Medicine and Animal Production, University of Naples “Federico II”, 80137 Naples, Italy; (G.D.V.); (C.C.); (C.D.P.); (M.P.P.); (G.F.)
| |
Collapse
|
9
|
Evidence-Based Complementary and Alternative Orthopedic Veterinary Medicine. Vet Clin North Am Small Anim Pract 2022; 52:925-938. [PMID: 35562224 DOI: 10.1016/j.cvsm.2022.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The use of complementary and alternative veterinary medicine (CAVM) continues to become more widespread, especially for the management of chronic pain conditions such as canine osteoarthritis. Many patients have comorbidities that preclude traditional medical options, have not adequately responded to conventional therapies, or have owners interested in pursuing a complementary approach. Evidence-based CAVM can serve as a safe and effective adjunct to manage chronic pain conditions. There is growing evidence in the veterinary literature for the use of acupuncture and some herbal supplements in the multimodal management of canine osteoarthritis. The majority of evidence supporting chiropractic is limited to equine and human literature.
Collapse
|
10
|
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives. Animals (Basel) 2022; 12:ani12070812. [PMID: 35405802 PMCID: PMC8996831 DOI: 10.3390/ani12070812] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 03/17/2022] [Accepted: 03/20/2022] [Indexed: 11/22/2022] Open
Abstract
Simple Summary Chronic disorders of the intestinal tract (CID) are characterized by signs of inflammation of the intestine for a period of at least three weeks. Both humans and pets can be affected by these disorders. Different therapeutic approaches can be selected to treat patients and the use of natural products has been increased in the last decade, since oxidative stress plays a key role in the progression of the chronic intestinal disorders. In this review, the antioxidant proprieties of several natural products with potential for treatment of CID in human and veterinary medicine are highlighted. Unfortunately, few clinical trials report the use of these products for treating CID in humans and none in animals. Abstract Chronic intestinal disorders (CID) are characterized by persistent, or recurrent gastrointestinal (GI) signs present for at least three weeks. In human medicine, inflammatory bowel disease (IBD) is a group of chronic GI diseases and includes Crohn’s disease (CD) and ulcerative colitis (UC). On the other hand, the general term chronic enteropathies (CE) is preferred in veterinary medicine. Different therapeutic approaches to these diseases are used in both humans and pets. This review is focused on the use of traditional therapies and nutraceuticals with specific antioxidant properties, for the treatment of CID in humans and animal patients. There is strong evidence of the antioxidant properties of the nutraceuticals included in this review, but few studies report their use for treating CID in humans and none in animals. Despite this fact, the majority of the nutraceuticals described in the present article could be considered as promising alternatives for the regular treatment of CID in human and veterinary medicine.
Collapse
|
11
|
Al-Mohrej OA, Prada C, Leroux T, Shanthanna H, Khan M. Pharmacological Treatment in the Management of Glenohumeral Osteoarthritis. Drugs Aging 2022; 39:119-128. [DOI: 10.1007/s40266-021-00916-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/16/2021] [Indexed: 11/03/2022]
|